ONCOMED PHARMACEUTICALS INC


Updates from The Motley Fool

Latest updates on OncoMed Pharmaceuticals from Fool.com.
This Week in Biotech: Part 1

With the  SPDR S&P Biotech Index  up 47% over the trailing-12-month period, it's evident that inv...



Stock Performance

View Interactive OMED Charts
Sponsored by

Key Data Points

Primary metrics and data points about OncoMed Pharmaceuticals.
Current Price: $8.27
Prev Close: $8.27
Open: $8.51
Bid: $8.15
Ask: $30.00
Day's Range: $8.16 - $8.60
52wk Range: $8.07 - $23.98
Volume: 186,345
Avg Vol 174,440
Market Cap: $249M
P/E (ttm): -2.50
EPS (ttm): ($3.39)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about OncoMed Pharmaceuticals.
CAPS Rating 3 out of 5
 
29 Outperform
3 Underperform
CAPS All Stars
 
3 Outperform
1 Underperform

How do you think OncoMed Pharmaceuticals will perform against the market?



You pick for OncoMed Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Paul J. Hastings, CEO

100% Approve

Based on 3 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for OncoMed Pharmaceuticals.

ONCOMED PHARMACEUTICALS INC

  • Exchange: NASDAQ